carvedilol has been researched along with fenofibrate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gao, Y; Jiang, T; Sun, J; Wan, L; Wang, S; Wang, T; Zhang, C; Zhao, Q | 1 |
| Chang, D; Di, D; Gao, Y; Jiang, T; Liu, J; Wang, S; Zhu, W | 1 |
| Dunn, C; Halbert, GW; Khadra, I; Perrier, J; Wilson, CG | 1 |
1 review(s) available for carvedilol and fenofibrate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for carvedilol and fenofibrate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Poly dimethyl diallyl ammonium coated CMK-5 for sustained oral drug release.
Topics: Administration, Oral; Calorimetry, Differential Scanning; Carbazoles; Carbon; Carvedilol; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Fenofibrate; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nimodipine; Particle Size; Polyethylenes; Polymers; Porosity; Propanolamines; Quaternary Ammonium Compounds; Solubility | 2014 |
A geometric pore adsorption model for predicting the drug loading capacity of insoluble drugs in mesoporous carbon.
Topics: Adsorption; Carbazoles; Carbon; Carvedilol; Celecoxib; Chemistry, Pharmaceutical; Drug Carriers; Fenofibrate; Models, Chemical; Models, Molecular; Molecular Structure; Nitrogen; Nonlinear Dynamics; Porosity; Propanolamines; Reproducibility of Results; Solubility; Surface Properties; Technology, Pharmaceutical | 2015 |
Topography of Simulated Intestinal Equilibrium Solubility.
Topics: Acid-Base Equilibrium; Administration, Oral; Bile Acids and Salts; Body Fluids; Carvedilol; Chemistry, Pharmaceutical; Dosage Forms; Drug Liberation; Fenofibrate; Humans; Hydrogen-Ion Concentration; Indomethacin; Intestinal Absorption; Intestinal Secretions; Models, Biological; Monoglycerides; Osmolar Concentration; Phospholipids; Solubility; Surface-Active Agents | 2019 |